Tilray Announces Launch of New Medical Cannabis Brand, Symbios

Tilray, Inc. (“Tilray”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company,…

Aphria and Tilray Announce Launch of www.aphriatilraytogether.com

Shareholders Encouraged to Visit Joint Company Website for Information About the Proposed Aphria-Tilray Combination Anti-Trust Clearances…

Aphria and Tilray Combine to Create Largest Global Cannabis Company With Pro Forma Revenue of C$874 Million (US$685 Million)

Aphria Inc. (“Aphria”) (TSX: APHA and Nasdaq: APHA), a leading global cannabis company inspiring and empowering the worldwide community…

Tilray, Inc. Announces Pricing of its $90.4 Million Registered Offering at $4.76 per share

NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis…

COWEN analysts update Tilray as outperforming

Last week, COWEN analysts Vivien Azer and Steven Schneiderman updated their note on the cannabis company…